Related references
Note: Only part of the references are listed.Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: A Minnie Pearl Cancer Research Network Study
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors
Matthew H. Kulke et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Gastric carcinoids -: Biologic behavior and prognosis after differentiated treatment in relation to type
K Borch et al.
ANNALS OF SURGERY (2005)
Small-cell carcinomas of the gastrointestinal tract: A review
B Brenner et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
W Noda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
